Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  Check Out View Cart

Country Report

Medicated Skin Care in

Dermatologicals in Brazil

20 pages, Feb 2019

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

Cheaper and more expensive products perform better than those in the mid-priced segment

In 2018, mid-priced dermatologicals posted a weaker performance than both cheap and more expensive products. Consumers continued to focus on getting the best value for money, with many purchasing more affordable items in several categories so as to adapt to the still challenging economic climate in Brazil.

Weakening of various taboos provides opportunities for the development of new categories

Vaginal antifungals remained the fastest growing category in dermatologicals in 2018. Bayer has been responsible for introducing these products to the Brazilian market through the launch of its Gino Canesten brand.

COMPETITIVE LANDSCAPE

Bayer benefits from introducing a new dermatologicals category

The leading three players in dermatologicals continued to post positive performances in 2018, although Bayer recorded the strongest increase in value sales. This can be largely attributed to the ongoing success of its Gino Canesten brand in vaginal antifungals, with Bayer benefiting from being the only company present in this relatively new category.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Medicated Skin Care Market Sample Report Medicated Skin Care Market Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Brazil with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Brazil, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Brazil market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Medicated Skin Care in Brazil?
What are the major brands in Brazil?
What are the most popular formats for acne treatments?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Dermatologicals in Brazil - Category analysis

HEADLINES

PROSPECTS

Cheaper and more expensive products perform better than those in the mid-priced segment

Weakening of various taboos provides opportunities for the development of new categories

COMPETITIVE LANDSCAPE

Bayer benefits from introducing a new dermatologicals category

CATEGORY DATA

Table 1 Sales of Dermatologicals by Category: Value 2013-2018
Table 2 Sales of Dermatologicals by Category: % Value Growth 2013-2018
Table 3 NBO Company Shares of Dermatologicals: % Value 2014-2018
Table 4 LBN Brand Shares of Dermatologicals: % Value 2015-2018
Table 5 Forecast Sales of Dermatologicals by Category: Value 2018-2023
Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023

Consumer Health in Brazil - Industry Overview

EXECUTIVE SUMMARY

Consumer health continues to be one of the few industries to record positive growth

Generics gaining ground in the OTC category

Leading companies continue to invest in marketing activities to drive sales

Internet retailing continues to slowly gain share

Further solid growth anticipated over the forecast period

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 8 Life Expectancy at Birth 2013-2018

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2013-2018
Table 10 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 11 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 12 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 13 Distribution of Consumer Health by Format: % Value 2013-2018
Table 14 Distribution of Consumer Health by Format and Category: % Value 2018
Table 15 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Megatrends

Country Report

Dermatologicals in Brazil

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

Cheaper and more expensive products perform better than those in the mid-priced segment

Weakening of various taboos provides opportunities for the development of new categories

COMPETITIVE LANDSCAPE

Bayer benefits from introducing a new dermatologicals category

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Dermatologicals in Brazil - Category analysis

HEADLINES

PROSPECTS

Cheaper and more expensive products perform better than those in the mid-priced segment

Weakening of various taboos provides opportunities for the development of new categories

COMPETITIVE LANDSCAPE

Bayer benefits from introducing a new dermatologicals category

CATEGORY DATA

Consumer Health in Brazil - Industry Overview

EXECUTIVE SUMMARY

Consumer health continues to be one of the few industries to record positive growth

Generics gaining ground in the OTC category

Leading companies continue to invest in marketing activities to drive sales

Internet retailing continues to slowly gain share

Further solid growth anticipated over the forecast period

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

DEFINITIONS

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports